PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Calcium channel blockers effective for pregnant patient with vasospastic angina

Careful diagnosis and treatment of vasospastic angina in a pregnant patient allowed successful outcomes for both patient and child

2023-12-06
(Press-News.org) A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a calcium channel blocker, according to a case published in a special Cardio-Obstetrics issue of JACC: Case Reports.

Vasospastic angina is an abnormality of the coronary artery. It presents as chest pain that is caused by coronary artery spasm. It can result in recurrent episodes of angina, including at rest, and can progress into coronary microvascular disfunction, acute myocardial infarction, ventricular arrythmias and even sudden cardiac death. VSA can be triggered during pregnancy when hormonal and nervous system changes occur.

This case presents a patient with no medical history who was in the process of trying to conceive. VSA is often overlooked in patients presenting with chest pain but can result in acute myocardial infarction (heart attack) in pregnant women. Due to its risks on pregnancy, it is important for clinicians to make a definitive diagnosis of VSA, determine its severity and provide proper treatment.

People with VSA are usually treated with calcium channel blockers, however, there is some concern of their safety when prescribed to pregnant people.

“Pregnant patients with vasospastic angina may require special management,” said Kota Murai, MD, Ph.D., a cardiologist at the Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan and an author of the study. “Clinicians must be able to accurately assess the advantages and disadvantages of certain VSA treatments and determine which is most beneficial to the health of both the mother and child. This case offers clear evidence of the advantages of the careful management of calcium channel blockers for people who are pregnant or trying to get pregnant.”

Calcium channel blockers are under speculation for pregnant patients due to reports of teratogenicity in animal studies. They are unlicensed for use in pregnancy in many countries. However, study authors conclude that calcium channel blockers—such as diltiazem—should be considered under certain conditions. Conditions include prior consultation with the patient, family, obstetricians and cardiologists, invasive catheterization and testing.

To achieve the patient’s diagnosis and determine perinatal cardiovascular risk, doctors performed invasive coronary catheterization and vasospasm provocation testing, which resulted in sub-occlusion in the left main trunk (LMT) with chest pain, ST segment depression in the V4–6 leads and hypotension. She was then administered an infusion of isosorbide mononitrate and nicorandil, which alleviated her symptoms. After testing, the patient was confirmed to have severe vasospastic angina and was administered a calcium channel blocker.

The patient was prescribed Diltiazem 200 mg daily and successfully conceived shortly after treatment. The effectiveness of diltiazem was confirmed when she experienced chest pain after treatment was temporarily discontinued due to hyperemesis gravidarum.

Her pregnancy progressed without VSA symptoms after the second trimester and there were no signs of abnormal development of the fetus. After delivery, the patient continued treatment with no recurrence of symptoms and the child obtained no disabilities.

This paper was published in a special cardio-obstetrics issue of JACC: Case Reports, an open access journal serving as a forum for promoting clinical cases and clinical problem solving. It accepts everyday educational or rare clinical cases, well described and with clear learning objectives. Furthermore, the journal aims to serve as a publication vehicle for early career cardiologists and members of the cardiovascular care team, and as a forum for mentorship on the review and publication process.

Other manuscripts published in the special issue include:

Successful Pregnancy after Cardiac Arrest in a Women with Severe Coronary Vasospasm Severe Aortic Stenosis in a Pregnant Patient Displaced by the Ukrainian-Russian War Management of Pregnancies Complicated by Type B Aortic Dissections Learn more about JACC: Case Reports at www.jacc.org/journal/case-reports.

For a copy of any of the papers in JACC: Case Reports, contact Olivia Walther at owalther@acc.org.

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

The ACC’s family of JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and family of specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.

###

 

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Jays jump in while crows hold out for the treat

Jays jump in while crows hold out for the treat
2023-12-06
New research has found that two similar species of birds – both capable of displaying self-control through delayed gratification – behave very differently around their favourite food when they have company. Published in the journal PLOS ONE, the study was led by researchers from Anglia Ruskin University (ARU) in Cambridge, UK, and the University of Cambridge, who compared the behaviour of two species of corvids: Eurasian jays (Garrulus glandarius) and New Caledonian crows (Corvus moneduloides). Although both are highly intelligent birds ...

Zinc shows promise as surprising emerging treatment for vaginal yeast infections

2023-12-06
New research could one day pave the way for the treatment of vaginal yeast infections,  by shedding new light on how microbes in the body absorb zinc. Around three quarters of women develop vaginal yeast infections at least once in their lifetime, and approximately 140 million women globally suffer from recurrent infections. Recurrent yeast infections can have an enormous impact of quality of life. Existing anti-fungal treatments are not always effective and resistance against these treatments is developing. Thrush is caused by a yeast called Candida. There are a number of species of Candida, but the one that causes most ...

Fungus-fighting protein could help overcome severe autoimmune disease and cancer

Fungus-fighting protein could help overcome severe autoimmune disease and cancer
2023-12-06
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease (IBS), type 1 diabetes, eczema and other chronic disorders, new research from The Australian National University (ANU) has found.  The discovery could pave the way for new and more effective drugs, without the nasty side effects of existing treatments. In addition to helping to manage severe autoimmune conditions, the breakthrough could also help treat all types of cancer.   The scientists have discovered ...

UMass Amherst researchers develop grassroots framework for managing environmental commons

UMass Amherst researchers develop grassroots framework for managing environmental commons
2023-12-06
December 6, 2023   UMass Amherst Researchers Develop Grassroots Framework for Managing Environmental Commons New tool relies on a foundation of local traditional ecological and social knowledge for more      just, sustainable and resilient conservation strategy AMHERST, Mass. – A team of sustainability scientists at the University of Massachusetts Amherst recently announced in the journal PLOS ONE that they have developed a community-based framework, founded on extensive local and traditional knowledge, to help assess and respond to the kinds of ecological threats ...

The ocean may be storing more carbon than estimated in earlier studies

The ocean may be storing more carbon than estimated in earlier studies
2023-12-06
The ocean's capacity to store atmospheric carbon dioxide is some 20% greater than the estimates contained in the latest IPCC report1. These are the findings of a study to be published in the journal Nature on December 6, 2023, led by an international team including a biologist from the CNRS2. The scientists looked at the role played by plankton in the natural transport of carbon from surface waters down to the seabed. Plankton gobble up carbon dioxide and, as they grow, convert it into organic tissue via photosynthesis. When they die, part of ...

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses
2023-12-06
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics. mRNA - or ‘messenger ribonucleic acid’ - is the genetic material that tells cells in the body how to make a specific protein. Researchers from the Medical Research Council (MRC) Toxicology Unit have discovered that the cellular ...

New protein linked to early-onset dementia identified

2023-12-06
Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing them to target these proteins for diagnostic tests and treatments. But, in around 10% of cases of frontotemporal dementia, scientists had yet to identify the rogue protein. Now, scientists have pinpointed aggregated structures of the protein TAF15 in these cases. Frontotemporal dementia results from the degeneration of the frontal and temporal lobes of the brain, which control emotions, personality and behaviour, as well speech and understanding of words. ...

Stellar winds regulate growth of galaxies

Stellar winds regulate growth of galaxies
2023-12-06
Galactic winds enable the exchange of matter between galaxies and their surroundings. In this way, they limit the growth of galaxies, that is, their star formation rate. Although this had already been observed in the local universe, an international research team led by a CNRS scientist1 has just revealed—using MUSE,2 an instrument integrated into the European Southern Observatory’s (ESO) Very Large Telescope—the existence of the phenomenon in galaxies which are more than 7 billion years old and actively forming stars, the category to which most galaxies belong. The team’s ...

Study finds individuals with acne face social and professional stigma

2023-12-06
Brigham researchers found that individuals with darker skin tones and more severe acne were likely to face greater stigma  Researchers note the importance of treating acne as a medical problem and ensuring access to treatment    A new study highlights how stigmatizing attitudes about individuals with acne may influence social and professional perceptions. Led by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, the study ...

A type of allergy medicine might help treat lung cancer, research suggests

A type of allergy medicine might help treat lung cancer, research suggests
2023-12-06
New York, NY (December 6, 2023)—Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).   And in an early parallel study in humans, combining immunotherapy with dupilumab—an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma—boosted patients' immune systems, with one out of the six experiencing significant tumor reduction.   The findings were ...

LAST 30 PRESS RELEASES:

Cooler heads prevail: New research reveals best way to prevent dogs from overheating

UC Riverside medical school develops new curriculum to address substance use crisis

Food fussiness a largely genetic trait from toddlerhood to adolescence

Celebrating a century of scholarship: Isis examines the HSS at 100

Key biomarkers identified for predicting disability progression in multiple sclerosis

Study: AI could lead to inconsistent outcomes in home surveillance

Study: Networks of Beliefs theory integrates internal & external dynamics

Vegans’ intake of protein and essential amino acids is adequate but ultra-processed products are also needed

Major $21 million Australian philanthropic investment to bring future science into disease diagnosis

Innovating alloy production: A single step from ores to sustainable metals

New combination treatment brings hope to patients with advanced bladder cancer

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

UTIA researchers win grant for automation technology for nursery industry

Can captive tigers be part of the effort to save wild populations?

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Mysteries of the bizarre ‘pseudogap’ in quantum physics finally untangled

Study: Proteins in tooth enamel offer window into human wellness

New cancer cachexia treatment boosts weight gain and patient activity

Rensselaer researcher receives $3 million grant to explore gut health

Elam named as a Fellow of the Electrochemical Society

Study reveals gaps in access to long-term contraceptive supplies

Shining a light on the roots of plant “intelligence”

Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections

Pushing kidney-stone fragments reduces stones’ recurrence

Sweet success: genomic insights into the wax apple's flavor and fertility

New study charts how Earth’s global temperature has drastically changed over the past 485 million years, driven by carbon dioxide

Scientists say we have enough evidence to agree global action on microplastics

485 million-year temperature record of Earth reveals Phanerozoic climate variability

Atmospheric blocking slows ocean-driven glacier melt in Greenland

Study: Over nearly half a billion years, Earth’s global temperature has changed drastically, driven by carbon dioxide

[Press-News.org] Calcium channel blockers effective for pregnant patient with vasospastic angina
Careful diagnosis and treatment of vasospastic angina in a pregnant patient allowed successful outcomes for both patient and child